Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 96

1.

Point-of-care viral load monitoring: outcomes from a decentralized HIV programme in Malawi.

Nicholas S, Poulet E, Wolters L, Wapling J, Rakesh A, Amoros I, Szumilin E, Gueguen M, Schramm B.

J Int AIDS Soc. 2019 Aug;22(8):e25387. doi: 10.1002/jia2.25387.

2.

'I saw it as a second chance': A qualitative exploration of experiences of treatment failure and regimen change among people living with HIV on second- and third-line antiretroviral therapy in Kenya, Malawi and Mozambique.

Burns R, Borges J, Blasco P, Vandenbulcke A, Mukui I, Magalasi D, Molfino L, Manuel R, Schramm B, Wringe A.

Glob Public Health. 2019 Aug;14(8):1112-1124. doi: 10.1080/17441692.2018.1561921. Epub 2019 Jan 11.

3.

Effects of Exposure to Carbon Dioxide in Potash Miners.

Monsé C, Jettkant B, Schramm BKH, Broding HC, Knappe M, Michl M, Hoffmeyer F, Sucker K, Brüning T, Bünger J.

Adv Exp Med Biol. 2019;1150:1-10. doi: 10.1007/5584_2018_270.

PMID:
30242786
4.

HIV-1 drug resistance testing at second-line regimen failure in Arua, Uganda: avoiding unnecessary switch to an empiric third-line.

Fily F, Ayikobua E, Ssemwanga D, Nicholas S, Kaleebu P, Delaugerre C, Pasquier E, Amoros Quiles I, Balkan S, Schramm B.

Trop Med Int Health. 2018 Oct;23(10):1075-1083. doi: 10.1111/tmi.13131.

5.

Single low-dose primaquine for blocking transmission of Plasmodium falciparum malaria - a proposed model-derived age-based regimen for sub-Saharan Africa.

Taylor WR, Naw HK, Maitland K, Williams TN, Kapulu M, D'Alessandro U, Berkley JA, Bejon P, Okebe J, Achan J, Amambua AN, Affara M, Nwakanma D, van Geertruyden JP, Mavoko M, Lutumba P, Matangila J, Brasseur P, Piola P, Randremanana R, Lasry E, Fanello C, Onyamboko M, Schramm B, Yah Z, Jones J, Fairhurst RM, Diakite M, Malenga G, Molyneux M, Rwagacondo C, Obonyo C, Gadisa E, Aseffa A, Loolpapit M, Henry MC, Dorsey G, John C, Sirima SB, Barnes KI, Kremsner P, Day NP, White NJ, Mukaka M.

BMC Med. 2018 Jan 18;16(1):11. doi: 10.1186/s12916-017-0990-6.

6.

Effects of fat and exoskeletal mass on the mass scaling of metabolism in Carabidae beetles.

Schramm BW, Gudowska A, Antoł A, Labecka AM, Bauchinger U, Kozłowski J, Czarnoleski M.

J Insect Physiol. 2018 Apr;106(Pt 3):232-238. doi: 10.1016/j.jinsphys.2017.10.002. Epub 2017 Oct 13.

PMID:
29032157
7.

Mass scaling of metabolic rates in carabid beetles (Carabidae) - the importance of phylogeny, regression models and gas exchange patterns.

Gudowska A, Schramm BW, Czarnoleski M, Antoł A, Bauchinger U, Kozłowski J.

J Exp Biol. 2017 Sep 15;220(Pt 18):3363-3371. doi: 10.1242/jeb.159293. Epub 2017 Jul 19.

8.

Physical mechanism or evolutionary trade-off? Factors dictating the relationship between metabolic rate and ambient temperature in carabid beetles.

Gudowska A, Schramm BW, Czarnoleski M, Kozłowski J, Bauchinger U.

J Therm Biol. 2017 Aug;68(Pt A):89-95. doi: 10.1016/j.jtherbio.2016.11.009. Epub 2016 Nov 13.

PMID:
28689726
9.

Ungewöhnliche Thoraxschmerzen bei einem Jugendlichen.

di Natale A, Descloux A, Schramm B, Schwendinger M, Nocito A.

Praxis (Bern 1994). 2017;106(5):261-264. doi: 10.1024/1661-8157/a002613. German. No abstract available.

PMID:
28253809
10.

Mortality and clinical outcomes in children treated with antiretroviral therapy in four African vertical programmes during the first decade of paediatric HIV care, 2001-2010.

Ben-Farhat J, Schramm B, Nicolay N, Wanjala S, Szumilin E, Balkan S, Pujades-Rodríguez M.

Trop Med Int Health. 2017 Mar;22(3):340-350. doi: 10.1111/tmi.12830. Epub 2017 Jan 26.

11.

Selection of Plasmodium falciparum pfcrt and pfmdr1 polymorphisms after treatment with artesunate-amodiaquine fixed dose combination or artemether-lumefantrine in Liberia.

Otienoburu SD, Maïga-Ascofaré O, Schramm B, Jullien V, Jones JJ, Zolia YM, Houzé P, Ashley EA, Kiechel JR, Guérin PJ, Le Bras J, Houzé S.

Malar J. 2016 Sep 5;15:452. doi: 10.1186/s12936-016-1503-3.

12.

Hold your breath beetle-Mites!

Gudowska A, Drobniak SM, Schramm BW, Labecka AM, Kozlowski J, Bauchinger U.

Evolution. 2016 Jan;70(1):249-55. doi: 10.1111/evo.12827. Epub 2015 Dec 21.

PMID:
26689423
13.

Topic: Rare and Special Cases, The Real "Strange Cases".

Zarrinkhoo E, Miller J, Walker A, Weisman M, Towfigh S, Tushev R, Petkov I, Tsutsumi G, Leija C, Castillo E, Moncada F, Mendoza M, Morua AG, Bravo R, Azcarate A, Zavala H, Coman IS, Radu EV, David OI, Stoian AR, Strambu VE, Iancu C, Gheorghiu LI, Grigorean VT, Sinescu DR, Plesa E, Lupascu C, Straja DN, Iacobini MA, Ponten J, Luyer M, Nienhuijs S, Permekerlis A, Petousis S, Miroforidis A, Milias K, Kouridakis P, Park J, Kim D, Nakata R, Chihara N, Suzuki H, Watanabe M, Uchida E, Nakanaga H, Irie S, Endo Y, Sonoda H, Minamimura K, Kobayashi T, Hirata T, Mafune K, Milosevic P, Babovic M, Sorat D, Light D, Aawsaj Y, Horgan L, Latham L, Ceriani I, Livraghi L, Berselli M, Gambitta B, Galvanin J, Cotronea C, Pagano G, Farassino L, Ambrosoli A, Crespi A, Cocozza E, Kulic V, Matkovic M, Percevic G, Katayama T, Kumata Y, Ogawa E, Horikawa M, Yaguchi Y, Inaba T, Fukushima R, Jaroszewski D, Johnson K, Harold K, Mori M, Kumata M, Guarnieri F, Smaldone W, Gaspard M, Bomben F, Ceranto S, Gamarra MF, Soria MP, Olivero CF, Martinez MJ, Contin MP, Gómez JC, Jiménez-Valladolid D, Torres García A, Descloux A, Pohle S, Schramm B, Schneider U, Nocito A, Navarrete MC, Solis A, Ortega N, Bergamini S, Semeraro C, Armengol M, Cano ML, Torrecilla NO, Cavallaro G, Iorio O, Avallone M, Ruscio S, Rizzello M, Silecchia G, Butron T, Rubio E, Passas J, Sopeña R, Lagaron E, Silan F, Garcia V, Bernal J, Ortiz M, Guadarrama J, Shirai K, Lomas M, Shah BB, Degloorkar SS.

Hernia. 2015 Apr;19 Suppl 1:S317-27. doi: 10.1007/BF03355378. No abstract available.

PMID:
26518831
14.

The effect of dosing strategies on the therapeutic efficacy of artesunate-amodiaquine for uncomplicated malaria: a meta-analysis of individual patient data.

WorldWide Antimalarial Resistance Network (WWARN) AS-AQ Study Group, Adjuik MA, Allan R, Anvikar AR, Ashley EA, Ba MS, Barennes H, Barnes KI, Bassat Q, Baudin E, Björkman A, Bompart F, Bonnet M, Borrmann S, Brasseur P, Bukirwa H, Checchi F, Cot M, Dahal P, D'Alessandro U, Deloron P, Desai M, Diap G, Djimde AA, Dorsey G, Doumbo OK, Espié E, Etard JF, Fanello CI, Faucher JF, Faye B, Flegg JA, Gaye O, Gething PW, González R, Grandesso F, Guerin PJ, Guthmann JP, Hamour S, Hasugian AR, Hay SI, Humphreys GS, Jullien V, Juma E, Kamya MR, Karema C, Kiechel JR, Kremsner PG, Krishna S, Lameyre V, Ibrahim LM, Lee SJ, Lell B, Mårtensson A, Massougbodji A, Menan H, Ménard D, Menéndez C, Meremikwu M, Moreira C, Nabasumba C, Nambozi M, Ndiaye JL, Nikiema F, Nsanzabana C, Ntoumi F, Ogutu BR, Olliaro P, Osorio L, Ouédraogo JB, Penali LK, Pene M, Pinoges L, Piola P, Price RN, Roper C, Rosenthal PJ, Rwagacondo CE, Same-Ekobo A, Schramm B, Seck A, Sharma B, Sibley CH, Sinou V, Sirima SB, Smith JJ, Smithuis F, Somé FA, Sow D, Staedke SG, Stepniewska K, Swarthout TD, Sylla K, Talisuna AO, Tarning J, Taylor WR, Temu EA, Thwing JI, Tjitra E, Tine RC, Tinto H, Vaillant MT, Valecha N, Van den Broek I, White NJ, Yeka A, Zongo I.

BMC Med. 2015 Mar 31;13:66. doi: 10.1186/s12916-015-0301-z.

15.

Risk factors and mortality associated with resistance to first-line antiretroviral therapy: multicentric cross-sectional and longitudinal analyses.

Pinoges L, Schramm B, Poulet E, Balkan S, Szumilin E, Ferreyra C, Pujades-Rodríguez M.

J Acquir Immune Defic Syndr. 2015 Apr 15;68(5):527-35. doi: 10.1097/QAI.0000000000000513.

PMID:
25585301
16.

Polymorphisms in Plasmodium falciparum chloroquine resistance transporter and multidrug resistance 1 genes: parasite risk factors that affect treatment outcomes for P. falciparum malaria after artemether-lumefantrine and artesunate-amodiaquine.

Venkatesan M, Gadalla NB, Stepniewska K, Dahal P, Nsanzabana C, Moriera C, Price RN, Mårtensson A, Rosenthal PJ, Dorsey G, Sutherland CJ, Guérin P, Davis TME, Ménard D, Adam I, Ademowo G, Arze C, Baliraine FN, Berens-Riha N, Björkman A, Borrmann S, Checchi F, Desai M, Dhorda M, Djimdé AA, El-Sayed BB, Eshetu T, Eyase F, Falade C, Faucher JF, Fröberg G, Grivoyannis A, Hamour S, Houzé S, Johnson J, Kamugisha E, Kariuki S, Kiechel JR, Kironde F, Kofoed PE, LeBras J, Malmberg M, Mwai L, Ngasala B, Nosten F, Nsobya SL, Nzila A, Oguike M, Otienoburu SD, Ogutu B, Ouédraogo JB, Piola P, Rombo L, Schramm B, Somé AF, Thwing J, Ursing J, Wong RPM, Zeynudin A, Zongo I, Plowe CV, Sibley CH, Asaq Molecular Marker Study Group.

Am J Trop Med Hyg. 2014 Oct;91(4):833-843. doi: 10.4269/ajtmh.14-0031. Epub 2014 Jul 21. Erratum in: Am J Trop Med Hyg. 2015 May;92(5):1084. Am J Trop Med Hyg. 2019 Mar;100(3):766.

17.

Automated measurement of ommatidia in the compound eyes of beetles.

Schramm BW, Gudowska A, Kapustka F, Labecka AM, Czarnoleski M, Kozłowski J.

Biotechniques. 2015 Aug 1;59(2):99-101. doi: 10.2144/000114316. eCollection 2015 Aug.

18.

Efficacy of artesunate-amodiaquine and artemether-lumefantrine fixed-dose combinations for the treatment of uncomplicated Plasmodium falciparum malaria among children aged six to 59 months in Nimba County, Liberia: an open-label randomized non-inferiority trial.

Schramm B, Valeh P, Baudin E, Mazinda CS, Smith R, Pinoges L, Dhorda M, Boum Y 2nd, Sundaygar T, Zolia YM, Jones JJ, Comte E, Houzé P, Jullien V, Carn G, Kiechel JR, Ashley EA, Guérin PJ.

Malar J. 2013 Jul 17;12:251. doi: 10.1186/1475-2875-12-251.

19.

Tolerability and safety of artesunate-amodiaquine and artemether-lumefantrine fixed dose combinations for the treatment of uncomplicated Plasmodium falciparum malaria: two open-label, randomized trials in Nimba County, Liberia.

Schramm B, Valeh P, Baudin E, Mazinda CS, Smith R, Pinoges L, Sundaygar T, Zolia YM, Jones JJ, Comte E, Bruneel A, Branger M, Jullien V, Carn G, Kiechel JR, Ashley EA, Guérin PJ.

Malar J. 2013 Jul 17;12:250. doi: 10.1186/1475-2875-12-250.

20.

Field evaluation of a simple fluorescence method for detection of viable Mycobacterium tuberculosis in sputum specimens during treatment follow-up.

Schramm B, Hewison C, Bonte L, Jones W, Camélique O, Ruangweerayut R, Swaddiwudhipong W, Bonnet M.

J Clin Microbiol. 2012 Aug;50(8):2788-90. doi: 10.1128/JCM.01232-12. Epub 2012 May 30.

21.

[2003 nursing regulation and the sequelae: plea for reform: a short guest performance on the unit].

Schramm B.

Pflege Z. 2012 Jan;65(1):36-9. German. No abstract available.

PMID:
22338258
22.

Heterogeneous decrease in malaria prevalence in children over a six-year period in south-western Uganda.

De Beaudrap P, Nabasumba C, Grandesso F, Turyakira E, Schramm B, Boum Y 2nd, Etard JF.

Malar J. 2011 May 18;10:132. doi: 10.1186/1475-2875-10-132.

23.

Immunovirological outcomes and resistance patterns at 4 years of antiretroviral therapy use in HIV-infected patients in Cambodia.

Pujades-Rodríguez M, Schramm B, Som L, Nerrienet E, Narom P, Chanchhaya N, Ferradini L, Balkan S.

Trop Med Int Health. 2011 Feb;16(2):205-13. doi: 10.1111/j.1365-3156.2010.02689.x. Epub 2010 Nov 19.

24.

Manifestation of speech and language disorders in children with hearing impairment compared with children with specific language disorders.

Keilmann A, Kluesener P, Freude C, Schramm B.

Logoped Phoniatr Vocol. 2011 Apr;36(1):12-20. doi: 10.3109/14015439.2010.517550. Epub 2010 Sep 17.

PMID:
20849246
25.

Auditory, speech and language development in young children with cochlear implants compared with children with normal hearing.

Schramm B, Bohnert A, Keilmann A.

Int J Pediatr Otorhinolaryngol. 2010 Jul;74(7):812-9. doi: 10.1016/j.ijporl.2010.04.008. Epub 2010 May 8.

PMID:
20452685
26.

[Development of a school curriculum compliant with the NRW guideline: retrospect after 6 years implementation].

Schramm B.

Pflege Z. 2010 Feb;63(2):108-10. German. No abstract available.

PMID:
20218169
27.

Canonical babbling and early hearing and language development of normal hearing children and children with cochlear implants.

Schramm B, Keilmann A, Brachmaier J.

Cochlear Implants Int. 2010 Jun;11 Suppl 1:375-8. doi: 10.1179/146701010X12671177990073. No abstract available.

PMID:
21756653
28.

Parent observation--an effective assessment method for early speech and language development?

Brachmaier J, Schramm B.

Cochlear Implants Int. 2010 Jun;11 Suppl 1:259-63. doi: 10.1179/146701010X12671177989039. No abstract available.

PMID:
21756627
29.

The prelexical development in children implanted by 16 months compared with normal hearing children.

Schramm B, Bohnert A, Keilmann A.

Int J Pediatr Otorhinolaryngol. 2009 Dec;73(12):1673-81. doi: 10.1016/j.ijporl.2009.08.023. Epub 2009 Sep 22.

PMID:
19775758
30.

[The oral exam in nursing education--3: Topics 8 and 12: managing complex nursing tasks].

Schramm B.

Pflege Z. 2009 Sep;62(9):550-2. German. No abstract available.

PMID:
19750975
31.

[Oral examination in nursing education 2: Topic 10: Developing an occupational identity].

Schramm B.

Pflege Z. 2009 Jul;62(7):434-6. German. No abstract available.

PMID:
19634527
32.

[Oral examination in nursing education--1: Topic 3: Competence oriented examination].

Schramm B.

Pflege Z. 2009 May;62(5):302-4. German. No abstract available.

PMID:
19492620
33.

Health financing reform in Kenya - assessing the social health insurance proposal.

Carrin G, James C, Adelhardt M, Doetinchem O, Eriki P, Hassan M, van den Hombergh H, Kirigia J, Koemm B, Korte R, Krech R, Lankers C, van Lente J, Maina T, Malonza K, Mathauer I, Okeyo TM, Muchiri S, Mumani Z, Nganda B, Nyikal J, Onsongo J, Rakuom C, Schramm B, Scheil-Adlung X, Stierle F, Whitaker D, Zipperer M.

S Afr Med J. 2007 Feb;97(2):130-5. Review.

PMID:
17404675
34.

Changes in clinical research in anaesthesia and intensive care from 1974-2004.

Teoh DC, Schramm B.

Anaesth Intensive Care. 2006 Dec;34(6):753-7.

35.

Improvement in immune parameters and human immunodeficiency virus-1 viral response in individuals treated with 16alpha-bromoepiandrosterone (HE2000).

Reading C, Dowding C, Schramm B, Garsd A, Onizuka-Handa N, Stickney D, Frincke J.

Clin Microbiol Infect. 2006 Nov;12(11):1082-8.

36.

Vaccinia-virus-induced cellular contractility facilitates the subcellular localization of the viral replication sites.

Schramm B, de Haan CA, Young J, Doglio L, Schleich S, Reese C, Popov AV, Steffen W, Schroer T, Locker JK.

Traffic. 2006 Oct;7(10):1352-67. Epub 2006 Aug 10.

37.

Vaccinia virus-induced microtubule-dependent cellular rearrangements.

Schepis A, Schramm B, de Haan CA, Locker JK.

Traffic. 2006 Mar;7(3):308-23.

38.

Cytoplasmic organization of POXvirus DNA replication.

Schramm B, Locker JK.

Traffic. 2005 Oct;6(10):839-46. Review.

39.

[Euthanasia of patients by nurses: a fate with many causes].

Schramm B.

Pflege Z. 2005 Feb;58(2):119-22. German. No abstract available.

PMID:
15754514
40.

Meeting report: EMBO workshop 'Cell Biology of Virus Infection', September 25-29, 2004, EMBL, Heidelberg, Germany.

Sodeik B, Schramm B, Suomalainen M, Locker JK.

Traffic. 2005 Apr;6(4):351-6. No abstract available.

41.

16alpha-Bromoepiandrosterone restores T helper cell type 1 activity and accelerates chemotherapy-induced bacterial clearance in a model of progressive pulmonary tuberculosis.

Hernández-Pando R, Aguilar-Leon D, Orozco H, Serrano A, Ahlem C, Trauger R, Schramm B, Reading C, Frincke J, Rook GA.

J Infect Dis. 2005 Jan 15;191(2):299-306. Epub 2004 Dec 9.

PMID:
15609241
42.

[Curriculum development in accordance with new a new guideline: NRW promotes rapid implementation of the decree].

Schramm B.

Pflege Z. 2004 May;57(5):343-6. German. No abstract available.

PMID:
15206184
43.

Cost of illness of atopic asthma and seasonal allergic rhinitis in Germany: 1-yr retrospective study.

Schramm B, Ehlken B, Smala A, Quednau K, Berger K, Nowak D.

Eur Respir J. 2003 Jan;21(1):116-22.

44.

Coreceptor phenotype of natural human immunodeficiency virus with nef deleted evolves in vivo, leading to increased virulence.

Jekle A, Schramm B, Jayakumar P, Trautner V, Schols D, De Clercq E, Mills J, Crowe SM, Goldsmith MA.

J Virol. 2002 Jul;76(14):6966-73.

45.

Dystonic reaction to propofol attenuated by benztropine (cogentin).

Schramm BM, Orser BA.

Anesth Analg. 2002 May;94(5):1237-40, table of contents. Review.

PMID:
11973196
46.

Coagulation studies in preoperative neurosurgical patients.

Schramm B, Leslie K, Myles PS, Hogan CJ.

Anaesth Intensive Care. 2001 Aug;29(4):388-92.

47.

Cytopathicity of human immunodeficiency virus type 1 primary isolates depends on coreceptor usage and not patient disease status.

Kreisberg JF, Kwa D, Schramm B, Trautner V, Connor R, Schuitemaker H, Mullins JI, van't Wout AB, Goldsmith MA.

J Virol. 2001 Sep;75(18):8842-7.

48.

Cytopathicity of human immunodeficiency virus type 2 (HIV-2) in human lymphoid tissue is coreceptor dependent and comparable to that of HIV-1.

Schramm B, Penn ML, Palacios EH, Grant RM, Kirchhoff F, Goldsmith MA.

J Virol. 2000 Oct;74(20):9594-600.

49.

Human immunodeficiency virus type 1 coreceptor preferences determine target T-cell depletion and cellular tropism in human lymphoid tissue.

Grivel JC, Penn ML, Eckstein DA, Schramm B, Speck RF, Abbey NW, Herndier B, Margolis L, Goldsmith MA.

J Virol. 2000 Jun;74(11):5347-51.

50.

Viral entry through CXCR4 is a pathogenic factor and therapeutic target in human immunodeficiency virus type 1 disease.

Schramm B, Penn ML, Speck RF, Chan SY, De Clercq E, Schols D, Connor RI, Goldsmith MA.

J Virol. 2000 Jan;74(1):184-92.

Supplemental Content

Loading ...
Support Center